Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.
AUTOR(ES)
Gross, G
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1195600Documentos Relacionados
- Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial.
- Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double‐blind, placebo‐controlled study
- Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon.
- The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study.
- Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial.